Suzanne Claxton

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 4

Top Topics

Intellectual Disability

Tyrosine Kinase

Top Venues

Life science alliance

Nature communications

Molecular psychiatry

This page only lists publications with an associated author ORCID identifier.

Publications

Margaux Silvestre, Kelvin Dempster, Simeon R Mihaylov, Suzanne Claxton, Sila K Ultanir
Cell type-specific expression, regulation and compensation of CDKL5 activity in mouse brain. Molecular psychiatry (2024)
Marisol Sampedro Castaneda, Lucas L Baltussen, Andre T Lopes, Yichen Qiu, Liina Sirvio, Simeon R Mihaylov, Suzanne Claxton, Jill C Richardson, Gabriele Lignani, Sila K Ultanir
Epilepsy-linked kinase CDKL5 phosphorylates voltage-gated calcium channel Cav2.3, altering inactivation kinetics and neuronal excitability. Nature communications 14 (1) (2023)
Flavia Roşianu, Simeon R Mihaylov, Noreen Eder, Antonie Martiniuc, Suzanne Claxton, Helen R Flynn, Shamsinar Jalal, Marie-Charlotte Domart, Lucy Collinson, Mark Skehel, Ambrosius P Snijders, Matthias Krause, Sharon A Tooze, Sila K Ultanir
Loss of NDR1/2 kinases impairs endomembrane trafficking and autophagy leading to neurodegeneration. Life science alliance 6 (2) (2022)
Amy W Lin, Kalbinder K Gill, Marisol Sampedro Castañeda, Irene Matucci, Noreen Eder, Suzanne Claxton, Helen R Flynn, Ambrosius P Snijders, Roger George, Sila K Ultanir
Chemical genetic identification of GAK substrates reveals its role in regulating Na+/K+-ATPase. Life science alliance 1 (6) (2018)